Amid the increasing number of coronavirus cases in India, the country?s first indigenous COVID-19 vaccine Covaxin has received DCGI nod to hold Phase I and II clinical human trials Read More
reported by at Moneycontrol
Amid the increasing number of coronavirus cases in India, the country?s first indigenous COVID-19 vaccine Covaxin has received DCGI nod to hold Phase I and II clinical human trials Read More
reported by at Moneycontrol
Recent Comments